{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:07:11Z","timestamp":1779836831656,"version":"3.53.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02289-9","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:20:11Z","timestamp":1775744411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal fluid and frontal cortex TMPRSS2 and ACE2 protein levels differ in Down syndrome and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Carlos","family":"Avil\u00e9s-Granados","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Gea-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"S\u00e1ez-Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlotte","family":"Granholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Carmona-Iragui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Salud","family":"Garc\u00eda-Ayll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"S\u00e1ez-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2289_CR1","first-page":"1686","volume":"61","author":"DE Afar","year":"2001","unstructured":"Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, Raitano AB, Jakobovits A (2001) Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res 61:1686\u20131922","journal-title":"Cancer Res"},{"key":"2289_CR2","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/alz.13692","volume":"20","author":"I Aldecoa","year":"2024","unstructured":"Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD, Guzman SJ, Hamlett ED, Head E, Perez SE, Potter H, Molina-Porcel L, Raha\u2010Chowdhury R, Wisniewski T, Yong WH, Zaman S, Ghosh S, Mufson EJ, Granholm A (2024) Down Syndrome Biobank Consortium: A perspective. Alzheimer\u2019s Dement 20:2262\u20132272. https:\/\/doi.org\/10.1002\/alz.13692","journal-title":"Alzheimer\u2019s Dement"},{"key":"2289_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102612","author":"MF Bachmann","year":"2025","unstructured":"Bachmann MF, Mohsen MO, Speiser DE (2025) The impact of viral evolution on vaccine development for SARS-CoV-2. Curr Opin Immunol. https:\/\/doi.org\/10.1016\/j.coi.2025.102612","journal-title":"Curr Opin Immunol"},{"key":"2289_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12541","author":"ED van Bakker","year":"2024","unstructured":"Bakker ED, van Maurik IS, Zwan MD, Gillissen F, van der Veere PJ, Bouwman FH, Pijnenburg YAL, van der Flier WM (2024) Impact of COVID-19 pandemic on mortality rate in memory clinic patients. Alzheimer\u2019s Dementia: Diagn Assess Dis Monit. https:\/\/doi.org\/10.1002\/dad2.12541","journal-title":"Alzheimer\u2019s Dementia: Diagn Assess Dis Monit"},{"key":"2289_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","volume":"15","author":"C Ballard","year":"2016","unstructured":"Ballard C, Mobley W, Hardy J, Williams G, Corbett A (2016) Dementia in Down\u2019s syndrome. Lancet Neurol 15:622\u2013636. https:\/\/doi.org\/10.1016\/S1474-4422(16)00063-6","journal-title":"Lancet Neurol"},{"key":"2289_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1352\/1944-7558-120.6.481","volume":"120","author":"B Benejam","year":"2015","unstructured":"Benejam B, Fortea J, Molina-L\u00f3pez R, Videla S (2015) Patterns of Performance on the modified cued recall test in Spanish adults With Down syndrome with and without dementia. Am J Intellect Dev Disabil 120:481\u2013489. https:\/\/doi.org\/10.1352\/1944-7558-120.6.481","journal-title":"Am J Intellect Dev Disabil"},{"key":"2289_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","volume":"40","author":"S Beyerstedt","year":"2021","unstructured":"Beyerstedt S, Casaro EB, Rangel \u00c9B (2021) COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis 40:905\u2013919. https:\/\/doi.org\/10.1007\/s10096-020-04138-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2289_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01903-23","author":"ACM Boon","year":"2024","unstructured":"Boon ACM, Bricker TL, Fritch EJ, Leist SR, Gully K, Baric RS, Graham RL, Troan BV, Mahoney M, Janetka JW (2024) Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19. J Virol. https:\/\/doi.org\/10.1128\/jvi.01903-23","journal-title":"J Virol"},{"key":"2289_CR9","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer\u2019s disease. pp 127\u2013140","DOI":"10.1007\/978-3-7091-6467-9_11"},{"key":"2289_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40035-022-00316-y","volume":"11","author":"F Chen","year":"2022","unstructured":"Chen F, Chen Y, Wang Y, Ke Q, Cui L (2022) The COVID-19 pandemic and Alzheimer\u2019s disease: mutual risks and mechanisms. Transl Neurodegener 11:40. https:\/\/doi.org\/10.1186\/s40035-022-00316-y","journal-title":"Transl Neurodegener"},{"key":"2289_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41398-023-02692-z","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Chen J, Lei Z, Zhang F, Zeng L-H, Wu X, Li S, Tan J (2023) Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-\u03b2-associated pathology in APP\/PS1 mouse model of Alzheimer\u2019s disease. Transl Psychiatry 13:396. https:\/\/doi.org\/10.1038\/s41398-023-02692-z","journal-title":"Transl Psychiatry"},{"key":"2289_CR12","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.2353\/ajpath.2010.090665","volume":"176","author":"Y-W Chen","year":"2010","unstructured":"Chen Y-W, Lee M-S, Lucht A, Chou F-P, Huang W, Havighurst TC, Kim K, Wang J-K, Antalis TM, Johnson MD, Lin C-Y (2010) TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 176:2986\u20132996. https:\/\/doi.org\/10.2353\/ajpath.2010.090665","journal-title":"Am J Pathol"},{"key":"2289_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/cells13030203","volume":"13","author":"C Cianfarini","year":"2024","unstructured":"Cianfarini C, Hassler L, Wysocki J, Hassan A, Nicolaescu V, Elli D, Gula H, Ibrahim AM, Randall G, Henkin J, Batlle D (2024) Soluble angiotensin-converting enzyme 2 protein improves survival and lowers viral titers in lethal mouse model of severe acute respiratory syndrome coronavirus type 2 infection with the delta variant. Cells 13:203. https:\/\/doi.org\/10.3390\/cells13030203","journal-title":"Cells"},{"key":"2289_CR14","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.7326\/M20-4986","volume":"174","author":"AK Clift","year":"2020","unstructured":"Clift AK, Coupland CAC, Keogh RH, Hemingway H, Hippisley-Cox J (2020) COVID-19 mortality risk in down syndrome: results from a cohort study of 8 million adults. Ann Intern Med 174:M20\u20134986. https:\/\/doi.org\/10.7326\/M20-4986","journal-title":"Ann Intern Med"},{"key":"2289_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.684874","author":"H Cui","year":"2021","unstructured":"Cui H, Su S, Cao Y, Ma C, Qiu W (2021) The altered anatomical distribution of ACE2 in the brain With Alzheimer\u2019s disease pathology. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.684874","journal-title":"Front Cell Dev Biol"},{"key":"2289_CR16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/ijms22041687","volume":"22","author":"Q Ding","year":"2021","unstructured":"Ding Q, Shults NV, Gychka SG, Harris BT, Suzuki YJ (2021) Protein expression of angiotensin-converting enzyme 2 (ACE2) is upregulated in brains with alzheimer\u2019s disease. Int J Mol Sci 22:1687. https:\/\/doi.org\/10.3390\/ijms22041687","journal-title":"Int J Mol Sci"},{"key":"2289_CR17","doi-asserted-by":"publisher","first-page":"110678","DOI":"10.1016\/j.biopha.2020.110678","volume":"131","author":"M Dong","year":"2020","unstructured":"Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L (2020) ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 131:110678. https:\/\/doi.org\/10.1016\/j.biopha.2020.110678","journal-title":"Biomed Pharmacother"},{"key":"2289_CR18","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s10072-021-05091-8","volume":"42","author":"A Emami","year":"2021","unstructured":"Emami A, Javanmardi F, Akbari A, Asadi-Pooya AA (2021) COVID-19 in patients with Down syndrome. Neurol Sci 42:1649\u20131652. https:\/\/doi.org\/10.1007\/s10072-021-05091-8","journal-title":"Neurol Sci"},{"key":"2289_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.33588\/rn.5708.2013259","volume":"57","author":"S Esteba-Castillo","year":"2013","unstructured":"Esteba-Castillo S, Dalmau-Bueno A, Ribas-Vidal N, Vil\u00e0-Alsina M, Novell-Alsina R, Garc\u00eda-Alba J (2013) Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down\u2019s Syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities. Rev Neurol 57:337\u2013346","journal-title":"Rev Neurol"},{"key":"2289_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","volume":"20","author":"J Fortea","year":"2021","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M (2021) Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol 20:930\u2013942. https:\/\/doi.org\/10.1016\/S1474-4422(21)00245-3","journal-title":"Lancet Neurol"},{"key":"2289_CR21","doi-asserted-by":"publisher","first-page":"e21745","DOI":"10.1096\/fj.202100051R","volume":"35","author":"M-S Garc\u00eda-Ayll\u00f3n","year":"2021","unstructured":"Garc\u00eda-Ayll\u00f3n M-S, Moreno-P\u00e9rez O, Garc\u00eda-Arriaza J, Ramos-Rinc\u00f3n J-M, Cort\u00e9s-G\u00f3mez M-\u00c1, Brinkmalm G, Andr\u00e9s M, Le\u00f3n-Ram\u00edrez J-M, Boix V, Gil J, Zetterberg H, Esteban M, Merino E, S\u00e1ez-Valero J (2021) Plasma ACE2 species are differentially altered in COVID-19 patients. FASEB J 35:e21745. https:\/\/doi.org\/10.1096\/fj.202100051R","journal-title":"FASEB J"},{"key":"2289_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2144\/00293PF02","volume":"29","author":"JC Gingrich","year":"2000","unstructured":"Gingrich JC, Davis DR, Nguyen Q (2000) Multiplex detection and quantitation of proteins on western blots using fluorescent probes. Biotechniques 29:636\u2013642. https:\/\/doi.org\/10.2144\/00293PF02","journal-title":"Biotechniques"},{"key":"2289_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00401-024-02743-9","volume":"147","author":"A-CE Granholm","year":"2024","unstructured":"Granholm A-CE, Englund E, Gilmore A, Head E, Yong WH, Perez SE, Guzman SJ, Hamlett ED, Mufson EJ (2024) Neuropathological findings in Down syndrome, Alzheimer\u2019s disease and control patients with and without SARS-COV-2: preliminary findings. Acta Neuropathol 147:92. https:\/\/doi.org\/10.1007\/s00401-024-02743-9","journal-title":"Acta Neuropathol"},{"key":"2289_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/J.JALZ.2018.05.008","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K (2018) The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: A review. Alzheimers Dement 14:1313\u20131333. https:\/\/doi.org\/10.1016\/J.JALZ.2018.05.008","journal-title":"Alzheimers Dement"},{"key":"2289_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L (2006) Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5:228\u2013234. https:\/\/doi.org\/10.1016\/S1474-4422(06)70355-6","journal-title":"Lancet Neurol"},{"key":"2289_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","volume":"76","author":"R Hithersay","year":"2019","unstructured":"Hithersay R, Startin CM, Hamburg S, Mok KY, Hardy J, Fisher EMC, Tybulewicz VLJ, Nizetic D, Strydom A (2019) Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol 76:152. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3616","journal-title":"JAMA Neurol"},{"key":"2289_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271\u2013280e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"2289_CR28","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3233\/JAD-215051","volume":"84","author":"S Ismael","year":"2021","unstructured":"Ismael S, Mirzahosseini G, Ahmed HA, Yoo A, Kassan M, Malik KU, Ishrat T (2021) Renin-angiotensin system alterations in the human alzheimer\u2019s disease brain. J Alzheimer\u2019s Disease 84:1473\u20131484. https:\/\/doi.org\/10.3233\/JAD-215051","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2289_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23:3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2289_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","volume":"8","author":"PG Kehoe","year":"2016","unstructured":"Kehoe PG, Wong S, Mulhim NAL, Palmer LE, Miners JS (2016) Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology. Alzheimers Res Ther 8:50. https:\/\/doi.org\/10.1186\/s13195-016-0217-7","journal-title":"Alzheimers Res Ther"},{"key":"2289_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s40478-021-01302-7","volume":"9","author":"SN Kurki","year":"2021","unstructured":"Kurki SN, Kantonen J, Kaivola K, Hokkanen L, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Puttonen H, Martola J, P\u00f6yh\u00f6nen M, Kero M, Tuimala J, Carp\u00e9n O, Kantele A, Vapalahti O, Tiainen M, Tienari PJ, Kaila K, H\u00e4stbacka J, Myllykangas L (2021) APOE \u03b54 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol Commun 9:199. https:\/\/doi.org\/10.1186\/s40478-021-01302-7","journal-title":"Acta Neuropathol Commun"},{"key":"2289_CR32","doi-asserted-by":"publisher","first-page":"e929","DOI":"10.1093\/infdis\/jiaf093","volume":"231","author":"MP Lennol","year":"2025","unstructured":"Lennol MP, Garc\u00eda-Ayll\u00f3n M-S, Avil\u00e9s-Granados C, Trasciatti C, Tolassi C, Quaresima V, Arici D, Cristillo V, Volonghi I, Caprioli F, Giuli V, De, Mariotto S, Ferrari S, Zanusso G, Ashton NJ, Zetterberg H, Blennow K, Padovani A, Pilotto A, S\u00e1ez-Valero J (2025) Increased cerebrospinal fluid angiotensin-converting enzyme 2 fragments as a read-out of brain infection in patients with COVID-19 encephalopathy. J Infect Dis 231:e929\u2013e940. https:\/\/doi.org\/10.1093\/infdis\/jiaf093","journal-title":"J Infect Dis"},{"key":"2289_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1001951","author":"MP Lennol","year":"2022","unstructured":"Lennol MP, Garc\u00eda-Ayll\u00f3n M-S, Esteban M, Garc\u00eda-Arriaza J, S\u00e1ez-Valero J (2022) Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1001951","journal-title":"Front Immunol"},{"key":"2289_CR34","doi-asserted-by":"publisher","first-page":"1120495","DOI":"10.3389\/fimmu.2023.1120495","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Sun L, Yue L, Xiao S (2023) Alzheimer\u2019s disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process. Front Immunol 14:1120495. https:\/\/doi.org\/10.3389\/fimmu.2023.1120495","journal-title":"Front Immunol"},{"issue":"7","key":"2289_CR35","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1038\/s41380-025-03006-z","volume":"30","author":"S Li","year":"2025","unstructured":"Li S, Sun J, Li H, Han Z, Wang T, Gao S, Zhu P, Chen Y, Yan P, Wang M, Liu G (2025) Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer\u2019s disease and COVID-19. Mol Psychiatry 30(7):3257\u20133268. https:\/\/doi.org\/10.1038\/s41380-025-03006-z","journal-title":"Mol Psychiatry"},{"key":"2289_CR36","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","volume":"81","author":"K-H Lim","year":"2020","unstructured":"Lim K-H, Yang S, Kim S-H, Joo J-Y (2020) Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer\u2019s disease. J Infect 81:e33\u2013e34. https:\/\/doi.org\/10.1016\/j.jinf.2020.06.072","journal-title":"J Infect"},{"issue":"1","key":"2289_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00401-025-02895-2","volume":"149","author":"MI Lioudyno","year":"2025","unstructured":"Lioudyno MI, Sevrioukov EA, Olivarria GM, Hitchcock L, Javonillo DI, Campos SM, Rivera I, Wright ST, Head E, Fortea J, Wisniewski T, Cuello AC, Do Carmo S, Lane TE, Busciglio J (2025) SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model. Acta Neuropathol 149(1):54. https:\/\/doi.org\/10.1007\/s00401-025-02895-2","journal-title":"Acta Neuropathol"},{"key":"2289_CR38","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/gerona\/glac083","volume":"77","author":"R MacLachlan","year":"2022","unstructured":"MacLachlan R, Kehoe PG, Miners JS (2022) Dysregulation of ACE-1 in normal aging and the early stages of Alzheimer\u2019s disease. J Gerontol Ser A 77:1775\u20131783. https:\/\/doi.org\/10.1093\/gerona\/glac083","journal-title":"J Gerontol Ser A"},{"key":"2289_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-1-59745-542-8_51","volume":"536","author":"ST Mathews","year":"2009","unstructured":"Mathews ST, Plaisance EP, Kim T (2009) Imaging systems for westerns: chemiluminescence vs. infrared detection. Methods Mol Biol 536:499\u2013513. https:\/\/doi.org\/10.1007\/978-1-59745-542-8_51","journal-title":"Methods Mol Biol"},{"key":"2289_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00005072-199405000-00012","volume":"53","author":"SS Mirra","year":"1994","unstructured":"Mirra SS, Gearing M, McKeel DW, Crain BJ, Hughes JP, van Belle G, Heyman A (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer\u2019s disease: a study of the Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). J Neuropathol Exp Neurol 53:303\u2013315. https:\/\/doi.org\/10.1097\/00005072-199405000-00012","journal-title":"J Neuropathol Exp Neurol"},{"key":"2289_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P, Hagelkr\u00fcys A, Wimmer RA, Stahl M, Leopoldi A, Garreta E, del Pozo CH, Prosper F, Romero JP, Wirnsberger G, Zhang H, Slutsky AS, Conder R, Montserrat N, Mirazimi A, Penninger JM (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181:905\u2013913e7. https:\/\/doi.org\/10.1016\/j.cell.2020.04.004","journal-title":"Cell"},{"key":"2289_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/S00401-019-01965-6","volume":"137","author":"SE Perez","year":"2019","unstructured":"Perez SE, Miguel JC, He B, Malek-Ahmadi M, Abrahamson EE, Ikonomovic MD, Lott I, Doran E, Alldred MJ, Ginsberg SD, Mufson EJ (2019) Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia. Acta Neuropathol 137:413\u2013436. https:\/\/doi.org\/10.1007\/S00401-019-01965-6","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2289_CR43","doi-asserted-by":"publisher","first-page":"e70004","DOI":"10.1111\/bpa.70004","volume":"35","author":"SE Perez","year":"2025","unstructured":"Perez SE, Nadeem M, He B, Miguel JC, Moreno DG, Moreno-Rodriguez M, Malek-Ahmadi M, Hales CM, Mufson EJ (2025) Spliceosome protein alterations differentiate hubs of the default mode connectome during the progression of Alzheimer\u2019s disease. Brain Pathol 35(5):e70004. https:\/\/doi.org\/10.1111\/bpa.70004","journal-title":"Brain Pathol"},{"issue":"8","key":"2289_CR44","doi-asserted-by":"publisher","first-page":"e70474","DOI":"10.1002\/alz.70474","volume":"21","author":"SE Perez","year":"2025","unstructured":"Perez SE, Miguel JC, Nadeem M, Malek-Ahmadi M, Hales CM, Head E, Mufson EJ (2025) U1-70K and U1A and tau pathogenesis in demented and non-demented individuals with Down syndrome. Alzheimers Dement 21(8):e70474. https:\/\/doi.org\/10.1002\/alz.70474","journal-title":"Alzheimers Dement"},{"key":"2289_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/IID3.1219","author":"PNK Pitchan Velammal","year":"2024","unstructured":"Pitchan Velammal PNK, Balasubramanian S, Ayoobkhan FS, Mohan GVK, Aggarwal P, Rabaan AA, Khan SA, Yasmin F, Koritala T, Surani SR (2024) COVID-19 in patients with Down syndrome: A systematic review. Immun Inflamm Dis. https:\/\/doi.org\/10.1002\/IID3.1219","journal-title":"Immun Inflamm Dis"},{"key":"2289_CR46","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbrc.2020.09.042","volume":"533","author":"J Qiao","year":"2020","unstructured":"Qiao J, Li W, Bao J, Peng Q, Wen D, Wang J, Sun B (2020) The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues. Biochem Biophys Res Commun 533:867\u2013871. https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.042","journal-title":"Biochem Biophys Res Commun"},{"key":"2289_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40478-023-01647-1","volume":"11","author":"L Reveret","year":"2023","unstructured":"Reveret L, Leclerc M, Emond V, Tremblay C, Loiselle A, Bourassa P, Bennett DA, H\u00e9bert SS, Calon F (2023) Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer\u2019s disease. Acta Neuropathol Commun 11:159. https:\/\/doi.org\/10.1186\/s40478-023-01647-1","journal-title":"Acta Neuropathol Commun"},{"key":"2289_CR48","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3233\/JAD-180282","volume":"64","author":"NP Rocha","year":"2018","unstructured":"Rocha NP, Toledo A, Corgosinho LTS, de Souza LC, Guimar\u00e3es HC, Resende EPF, Braz NFT, Gomes KB, e Silva ACS, Caramelli P, Teixeira AL (2018) Cerebrospinal fluid levels of angiotensin-converting enzyme are associated with Amyloid-\u03b242 burden in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 64:1085\u20131090. https:\/\/doi.org\/10.3233\/JAD-180282","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2289_CR49","doi-asserted-by":"publisher","first-page":"30346","DOI":"10.1038\/s41598-024-81810-3","volume":"14","author":"J S\u00e1ez-Leyva","year":"2024","unstructured":"S\u00e1ez-Leyva J, Lennol MP, Avil\u00e9s-Granados C, Garc\u00eda-Ayll\u00f3n M-S, Guti\u00e9rrez A, Franc\u00e9s R, S\u00e1ez-Valero J (2024) Altered plasma levels of the SARS-CoV-2-related proteins ACE2 and TMPRSS2 in patients with Crohn\u2019s disease. Sci Rep 14:30346. https:\/\/doi.org\/10.1038\/s41598-024-81810-3","journal-title":"Sci Rep"},{"key":"2289_CR50","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1046\/j.1471-4159.1999.721600.x","volume":"72","author":"J S\u00e1ez-Valero","year":"1999","unstructured":"S\u00e1ez-Valero J, Sberna G, McLean CA, Small DH (1999) Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurochem 72:1600\u20131608. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.721600.x","journal-title":"J Neurochem"},{"key":"2289_CR51","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/acn3.52299","volume":"12","author":"JD Santoro","year":"2025","unstructured":"Santoro JD, Eduthan NP, Khoshnood MM, Jafarpour S, Boyd NK, Vogel BN, Nguyen L, Kazerooni L, Britton E, Lyford HR, Galbraith MD, Rachubinski AL, Espinosa JM (2025) Evidence of blood\u2013brain barrier dysfunction and <\u2009scp>CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Ann Clin Transl Neurol 12:805\u2013820. https:\/\/doi.org\/10.1002\/acn3.52299","journal-title":"Ann Clin Transl Neurol"},{"key":"2289_CR52","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.3390\/jcm12206618","volume":"12","author":"TM Seccia","year":"2023","unstructured":"Seccia TM, Shagjaa T, Morpurgo M, Caroccia B, Sanga V, Faoro S, Venturini F, Iadicicco G, Lococo S, Mazzitelli M, Farnia F, Fioretto P, Kobayashi Y, Gregori D, Rossi GP (2023) Randomized clinical trial of nafamostat mesylate, a potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia. J Clin Med 12:6618. https:\/\/doi.org\/10.3390\/jcm12206618","journal-title":"J Clin Med"},{"issue":"1","key":"2289_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12974-023-02979-4","volume":"20","author":"MA Shahbaz","year":"2023","unstructured":"Shahbaz MA, Kuivanen S, Lampinen R, Mussalo L, Hron T, Z\u00e1vodn\u00e1 T, Kanninen KM (2023) Human-derived air\u2013liquid interface cultures decipher Alzheimer\u2019s disease\u2013SARS-CoV-2 crosstalk in the olfactory mucosa. J Neuroinflammation 20(1):299 https:\/\/doi.org\/10.1186\/s12974-023-02979-4","journal-title":"J Neuroinflammation"},{"key":"2289_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj4735","author":"MR Shaker","year":"2024","unstructured":"Shaker MR, Slonchak A, Al-mhanawi B, Morrison SD, Sng JDJ, Cooper-White J, Khromykh AA, Wolvetang EJ (2024) Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.adj4735","journal-title":"Sci Adv"},{"key":"2289_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad241","author":"HM Tayler","year":"2024","unstructured":"Tayler HM, MacLachlan R, G\u00fczel \u00d6, Fisher RA, Skrobot OA, Abulfadl MA, Kehoe PG, Miners JS (2024) Altered gene expression within the renin\u2013angiotensin system in normal aging and dementia. J Gerontol Ser A. https:\/\/doi.org\/10.1093\/gerona\/glad241","journal-title":"J Gerontol Ser A"},{"key":"2289_CR56","doi-asserted-by":"publisher","unstructured":"Toma I, De Dierssen M (2021) Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Sci Rep 11:1930. https:\/\/doi.org\/10.1038\/s41598-021-81451-w","DOI":"10.1038\/s41598-021-81451-w"},{"issue":"1","key":"2289_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12974-023-02979-4","volume":"20","author":"J Topinka","year":"2023","unstructured":"Topinka J, Vapalahti O, Chew S, Balistreri G, Kanninen KM (2023) Human-derived air-liquid interface cultures decipher Alzheimer\u2019s disease-SARS-CoV-2 crosstalk in the olfactory mucosa. J Neuroinflammation 20(1):299. https:\/\/doi.org\/10.1186\/s12974-023-02979-4","journal-title":"J Neuroinflammation"},{"key":"2289_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70061","author":"E De Verhulst","year":"2025","unstructured":"Verhulst E, Bruyn M, De, Berckmans P, Sim Y, Augustyns K, Pintelon I, Berg M, Wielendaele P, Van, Lambeir A, Sterckx YG-J, Nelissen I, De Meester I (2025) Human Transmembrane Serine Protease 2 (TMPRSS2) on human seminal fluid extracellular vesicles is proteolytically active. J Extracell Vesicles. https:\/\/doi.org\/10.1002\/jev2.70061","journal-title":"J Extracell Vesicles"},{"key":"2289_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.789180","author":"J Wang","year":"2022","unstructured":"Wang J, Zhao H, An Y (2022) ACE2 shedding and the role in COVID-19. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2021.789180","journal-title":"Front Cell Infect Microbiol"},{"key":"2289_CR60","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41467-024-45628-x","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Hu S, Popowski KD, Liu S, Zhu D, Mei X, Li J, Hu Y, Dinh P-UC, Wang X, Cheng K (2024) Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2. Nat Commun 15:2236. https:\/\/doi.org\/10.1038\/s41467-024-45628-x","journal-title":"Nat Commun"},{"key":"2289_CR61","doi-asserted-by":"publisher","first-page":"102643","DOI":"10.1016\/j.jbc.2022.102643","volume":"298","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Sun S, Du C, Hu K, Zhang C, Liu M, Wu Q, Dong N (2022) Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation. J Biol Chem 298:102643. https:\/\/doi.org\/10.1016\/j.jbc.2022.102643","journal-title":"J Biol Chem"},{"key":"2289_CR62","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5114\/fn.2021.109495","volume":"59","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Li W, Lukiw W (2021) Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer\u2019s disease brain. Folia Neuropathol 59:232\u2013238. https:\/\/doi.org\/10.5114\/fn.2021.109495","journal-title":"Folia Neuropathol"},{"key":"2289_CR63","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","volume":"8","author":"A Zoufaly","year":"2020","unstructured":"Zoufaly A, Poglitsch M, Aberle JH, Hoepler W, Seitz T, Traugott M, Grieb A, Pawelka E, Laferl H, Wenisch C, Neuhold S, Haider D, Stiasny K, Bergthaler A, Puchhammer-Stoeckl E, Mirazimi A, Montserrat N, Zhang H, Slutsky AS, Penninger JM (2020) Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med 8:1154\u20131158. https:\/\/doi.org\/10.1016\/S2213-2600(20)30418-5","journal-title":"Lancet Respir Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02289-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02289-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02289-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:59:31Z","timestamp":1779836371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02289-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02289-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethic Committee at the Miguel Hernandez University (IN.JSV.04:20) and it was carried out in accordance with the Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have stated explicitly that there are no conflicts of interest in connection with this article. HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant and at advisory boards for Abbvie, AC Immune, ALZPath, AriBio, Beckman-Coulter, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Neurimmune, Novartis, Ono Pharma, Prothena, Quanterix, Roche Diagnostics, Sunbird Bio, Sanofi and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. JF reported receiving personal fees for service on the advisory boards, adjudication committees or speaker honoraria from ACImmune, Adamed, Alzheon, Biogen, Eisai, Esteve, Fujirebio, Ionis, Labo-ratorios Carnot, Life Molecular Imaging, Lilly, Lundbeck, Novo Nordisk,Perha, Roche, Zamb\u00f3n and outside the submitted work. MCI reported receiving personal fees for service on the advisory boards, speaker honoraria or educational activities from Esteve, Lilly, Neuraxpharm, Adium Pharma, and Roche Diagnostics, outside this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}